The National Register plays a vital role in supporting the National Cervical Screening Program and the National Bowel Cancer Screening Program.

The three main functions of the National Register are to:

  • send invitation and reminder letters to participants
  • provide a safety net for when a person is at risk
  • provide a history of screening results.

Healthcare providers can also support participants to complete requests to the National Register, such as requesting to defer their next screening date.

Accessing the National Register

The National Cancer Screening Register has released a Healthcare Provider Portal and integration with clinical information systems to enable providers (e.g. general practitioners, nurses, and other specialists) to access and submit bowel and cervical screening data electronically in a self-service fashion.

The introduction of the Portal provides an alternative for interacting with the National Register to reduce paper, fax and phone calls, while also making it easier for healthcare professionals to submit information.

For detailed steps on how to be granted access to participant data and manage your patient’s participation in the bowel and cervical screening programs, you will need to refer to the Accessing the National Register page. If you experience any issues, call us on 1800 627 701 to speak to a member of our Contact Centre team.

   

Healthcare provider

This information is for healthcare providers who provide cervical or bowel screening services for program participants, including: 

  • general practitioners (GPs) 
  • nurses trained in cervical or bowel screening
  • specialists such as colposcopists, gynaecologists and gastroenterologists 
  • Aboriginal and Torres Strait Islander healthcare practitioners.

You can use the National Register to:

  • order your patient a National Bowel Cancer Screening Program Test Kit
  • check patient screening histories 
  • receive reminders for patients overdue for screening or follow-up
  • check and update patient details
  • manage patient program participation.
  • submit information about your patient, such as colonoscopy or colposcopy information
  • nominate other people to assist your patient, including another doctor or a personal representative.

The Healthcare Provider Portal enables you to complete these actions online. More information on how to register your access is available in the Healthcare Provider Portal User Guide.

For more information call 1800 627 701. Or refer to the Quick Start Guide for Healthcare Providers.

Pathology

This information is for laboratory providers, scientists and pathologists.

You can use the National Register to:

  • request and view screening histories
  • submit pathology results

The Healthcare Provider Portal enables you to complete these actions online. More information on how to register your access is available in the Healthcare Provider Portal User Guide.

For more information call 1800 627 701. Or refer to the Quick Start Guide for Healthcare Providers.

HPV positivity rates – benchmarking reports for pathology labs

One of the key elements of quality assessment for the National Cervical Screening Program is for pathology laboratories to routinely assess their HPV detection rate ('positivity rate'). Laboratories are expected to compare the HPV detection rate against national benchmarks. For more information, please see HPV positivity rates.

Colposcopy

This information is for specialists who perform colposcopies.

You can use the National Register to:

  • check patient screening history, reminders or if they are overdue for screening or follow-up
  • check and update patient details
  • complete the Colposcopy & Treatment Form to update recommendation and referral details
  • extract performance data for quality reporting.

The Healthcare Provider Portal enables you to complete these actions online. More information on how to register your access is available in the Healthcare Provider Portal User Guide.

For more information call 1800 627 701. Or refer to the Quick Start Guide for Colposcopists.

Colonoscopy

This information is for specialists who perform colonoscopies and other related tests.

You can use the National Register to:

  • check patient screening histories and test results
  • receive reminder letters if participants are overdue for screening or follow-up
  • check and update patient details
  • complete the colonoscopy and histopathology forms to update clinical recommendations and referral details
  • extract performance data for quality reporting.

The Healthcare Provider Portal enables you to complete these actions online. More information on how to register your access is available in the Healthcare Provider Portal User Guide.

For more information call 1800 627 701. Or refer to the Quick Start Guide for Healthcare Providers who perform colonoscopy and histopathology.

Information payments

Payments for program forms

Payments for submitting  program forms ended on 31 December 2020. The conclusion of these payments followed the introduction of new register functionality, including the Healthcare Provider Portal.

This has removed the need for healthcare providers and specialists to complete and submit paper-based program forms.

Program Forms

Program forms are still available at the National Bowel Cancer Screening Program website.

Alternative Pathway Providers – National Indigenous Bowel Screening

Primary health care services that were approved to participate in the National Indigenous Bowel Screening Pilot can continue to offer kits to their Indigenous patients aged 50-74 years.

These ‘Alternative Pathway Providers’ can access the Online Participant Details Form (Health Service Initiated) for completion and submission to the Register for all clients assessed for bowel screening and/or offered a kit.

Participant Details form (Health Service Initiated) – On-line Smart Form 

For use with clients and submission to the Register, services participating in the Pilot can access the online Participant Details form.

Patient privacy

The Privacy Policy describes why, when, and how we collect, use and disclose your information to operate the National Register.

Quick start guides

Important changes to the National Cervical Screening Program's (NCSP) Clinical Guidelines pathway for women at intermediate risk

Changes to the Guidelines for the clinical management of women at Intermediate Risk of cervical cancer will come into effect from 1 February 2021. This follows the Cancer Council Australia Clinical Guidelines working party review of national data from the first two years of the renewed program.

A review of the national clinical program data shows that women at Intermediate Risk whose follow-up test is human papillomavirus HPV (not-16/18) positive, Liquid Based Cytology (LBC) prediction negative, possible or  low grade squamous intraepithelial lesion (pLSIL or LSIL) will have a low likelihood of histologically-confirmed high grade squamous intraepithelial lesion (CIN2/3) or worse.

Please note that it is now recommended that: Women with a 12-month follow up HPV (not-16/18) result with LBC prediction negative, pLSIL or LSIL (Intermediate risk result) should be recommended to undertake a further HPV follow up test in 12 months’ time following their previous HPV test instead of referral to colposcopy.

Visit the NCSP website for more information.

Forms and guidelines

The introduction of the Healthcare Provider Portal provides you an alternate channel to interact with the National Register to eliminate paper, fax and phone calls, while also making it easier for healthcare professionals to submit information.

For example, if you are submitting information such as a colonoscopy or colposcopy form, you will not need to fill out patient details as they will be pre-populated in the portal.

You will be able to continue to send paper forms such as colonoscopy forms, adverse events forms and colposcopy forms, however Smart PDF forms will slowly be taken out of circulation.

Find out more about the Healthcare Provider Portal

The importance of reporting

Healthcare providers play a key role in delivering clinically appropriate advice, services, treatment and care while ensuring that program participants progress through the screening pathway. By completing and submitting information forms, you are providing essential data on participants and their outcomes to the National Register. 

Cervical Screening History Requests:

  • Pathology Laboratory Fax Template
    If you have not gained access to the Healthcare Provider Portal, use our fax template to request cervical screening history requests for the purpose of cervical screening management.
  • Healthcare Provider Cervical Screening History Request Fax Template
    If you have not gained access to the Healthcare Provider Portal, Healthcare providers can use our fax template to request cervical screening histories for the purpose of managing your patients’ cervical screening. Healthcare providers can request screening histories for up to 20 patients per day.

Cervical Clinical forms:

  • Colposcopy & Treatment Form
    Colposcopists and other healthcare providers who perform colposcopies will be required to notify prescribed cervical screening information to the Commonwealth Chief Medical Officer (CMO) through the National Register. The Colposcopy and Treatment form has been updated and should be used for all colposcopies performed from 1 December 2018.

Find out more about the new Colposcopy Quality Assurance Reports

Bowel Clinical forms:

  • Colonoscopy & Histopathology Report form
    Colonoscopists use this form to report an adverse outcome for a procedure relating to diagnostic investigation of a National Bowel Cancer Screening Program participant who has received a positive iFOBT result. Only use this form if this has not already been included in the Colonoscopy Report.

  • GP Assessment form
    General practitioners (GPs) use this form to provide information about consultations with bowel cancer screening patients who have received a positive iFOBT test result.

  • Histopathology Report form
    Histopathologists use this form to report the results for specimens collected during a surgical resection procedure for a National Bowel Cancer Screening Program patient with a positive iFOBT result.

  • Procedure Report – Adverse Events form
    Colonoscopists use this form to report adverse outcomes of diagnostic investigation procedures for National Bowel Cancer Screening Program patients who have received a positive iFOBT result. Only use this form if the information has not already been included in the colonoscopy and histopathology. 

For more information about Bowel Clinical forms, visit the National Bowel Cancer Screening Program website.